tirzepatide vs semaglutide results and key differences, weight loss (2026) Tirzepatide vs Semaglutide: Which Medication

Cardiovascular Risk Reduction Semaglutide SELECT trial (17,604 patients) demonstrated 20% MACE reduction in overweight/obese adults with established CVD

[18] Studies suggest that significant weight reduction can improve aspects of HPA axis function, reduce visceral adiposity, and improve insulin sensitivityall of which may contribute to more balanced cortisol dynamics

Promotes skin elasticity and smoothness through collagen supplementation

But I would say that the historical outcomes have been mixed in the asset management space

The risk of MALO in patients with chronic liver diseases and type 2 diabetes was lower if they initiated a GLP1 agonist and adhered to this treatment over time, Wester and colleagues wrote

GLIN I